Baxter International Inc. (BAX)
| Previous close | 36.51 |
| Open | 36.77 |
| Bid | 36.51 x 1100 |
| Ask | 36.51 x 1200 |
| Day's range | 36.36 - 36.81 |
| 52-week range | 31.01 - 50.21 |
| Volume | |
| Avg. volume | 3,820,603 |
| Market cap | 18.546B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.16 (3.18%) |
| Ex-dividend date | 29 Feb 2024 |
| 1y target est | N/A |
- Business Wire
Baxter Declares Quarterly Dividend
DEERFIELD, Ill., May 07, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on July 1, 2024, to stockholders of record as of May 31, 2024. The indicated annual dividend rate is $1.16 per share of common stock.
- Business Wire
Baxter Reports First-Quarter 2024 Results
DEERFIELD, Ill., May 02, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2024.
- Business Wire
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.
DEERFIELD, Ill., April 11, 2024--Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, announced the continued expansion of its Pharmaceuticals portfolio with five injectable product launches in the U.S.
